ホームMCPワークベンチSkills
ホームワークベンチ通知マイページ
llms.txt · MCPガイドプライバシーポリシー · 利用規約 · サポートv1.8.0
  1. ホーム
  2. /反応

Diisopropylamine → Telaprevir, (alpha-ketoamide bond reduced)-

HRID 391493
ノート
印刷プレビュー

反応式

HRID 391493 の反応式
[NH2:1][C@@H:2]([CH2:11][CH2:12][CH3:13])[CH:3]([OH:10])[C:4]([NH:6][CH:7]1[CH2:9][CH2:8]1)=[O:5].CCN=C=NCCCN(C)C.ON1C(=O)CCC1=O.[CH:33]1([C@H:39]([NH:61][C:62]([C:64]2[CH:69]=[N:68][CH:67]=[CH:66][N:65]=2)=[O:63])[C:40]([NH:42][C@@H:43]([C:57]([CH3:60])([CH3:59])[CH3:58])[C:44]([N:46]2[CH2:50][C@@H:49]3[CH2:51][CH2:52][CH2:53][C@@H:48]3[C@H:47]2[C:54](O)=[O:55])=[O:45])=[O:41])[CH2:38][CH2:37][CH2:36][CH2:35][CH2:34]1.C(NC(C)C)(C)C.O.ON1C2C=CC=CC=2N=N1.Cl.N[C@@H](CCC)C(O)C(NC1CC1)=O>CN(C=O)C.C(OCC)(=O)C>[CH:33]1([C@H:39]([NH:61][C:62]([C:64]2[CH:69]=[N:68][CH:67]=[CH:66][N:65]=2)=[O:63])[C:40]([NH:42][C@@H:43]([C:57]([CH3:60])([CH3:59])[CH3:58])[C:44]([N:46]2[CH2:50][C@@H:49]3[CH2:51][CH2:52][CH2:53][C@@H:48]3[C@H:47]2[C:54]([NH:1][C@@H:2]([CH2:11][CH2:12][CH3:13])[CH:3]([OH:10])[C:4]([NH:6][CH:7]2[CH2:8][CH2:9]2)=[O:5])=[O:55])=[O:45])=[O:41])[CH2:34][CH2:35][CH2:36][CH2:37][CH2:38]1
参加物実験手順後処理出典と根拠反応ノート

参加物

10

反応物 7

HCID 7912DiisopropylamineHCID 159081-Ethyl-3-(3'-dimethylaminopropyl)carbodiimide2 回HCID 80170N-HydroxysuccinimideHCID 27960291-Hydroxybenzotriazole hydrateHCID 23634852(1S,3aR,6aS)-(2S)-2-Cyclohexyl-N-(2-pyrazinylcarbonyl)glycyl-3-methyl-L-valyloctahydrocyclopenta(c)pyrrole-1-carboxylic acidHCID 23634853
(3S)-3-Amino-N-cyclopropyl-2-hydroxyhexanamide
HCID 66656935Hexanamide, 3-amino-N-cyclopropyl-2-hydroxy-, hydrochloride (1:1), (3S)-

生成物 1

HCID 23634854Telaprevir, (alpha-ketoamide bond reduced)-

試薬・触媒・溶媒 2

HCID 6228Dimethylformamide溶媒HCID 8857Ethyl Acetate溶媒

実験手順

The title compound is prepared from the hydroxy-amino amide product of Step g by condensation with the appropriate acid in the presence of a coupling reagent such as, e.g., EDCI and HOSu. Specifically, in a flask containing 1.2 eq. of (1S,3aR,6aS)-2-((S)-2-((S)-2-cyclohexyl-2-(pyrazine-2-carboxamido)acetamido)-3,3-dimethylbutanoyl)octahydrocyclopenta[c]pyrrole-1-carboxylic acid (1.59 g) in 20 mL of DMF, is added 2.5 eq. of diisopropylamine (980 uL), 1.2 eq. N-hydroxybenzotriazole hydrate (411 mg) and 1.3 eq. of EDCI (558 mg). After 15 minutes of stirring at the room temperature, 1.0 eq. of (3S)-3-amino-N-cyclopropyl-2-hydroxyhexanamide hydrochloride (500 mg) is added to the mixture. After another 24 hours, the reaction mixture is diluted into 400 mL of ethyl acetate. The organic phase of the mixture is washed with HCl (1N), water, saturated sodium bicarbonate solution, brine, and then dried over MgSO4. The crude product is purified by chromatography on silica (ethyl acetate 70-100% in Hexanes) to give the tile compound.

後処理

  1. additionis added to the mixture
  2. washThe organic phase of the mixture is washed with HCl (1N), water, saturated sodium bicarbonate solution, brine
  3. dry with materialdried over MgSO4
  4. customThe crude product is purified by chromatography on silica (ethyl acetate 70-100% in Hexanes)
  5. customto give the tile compound

出典と根拠

ORDレコード
ord-14f30c26ba11478ba8b90b3dbf48510c
出典データセット
uspto-grants-2013_02
DOI
10.6084/m9.figshare.5104873.v1
特許番号
US08383858B2

反応ノート

読み込み中…

このページの内容参加物実験手順後処理出典と根拠反応ノート